메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Yoo-Young Lee (Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine) Yen-Ling Lai (Department of Obstetrics and Gynecology, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu, Taiwan) 김명선 ((학) 가톨릭학원가톨릭대학교 성빈센트병원) Koping Chang (Department of Pathology, National Taiwan University Hospital, Taipei, Taiwan) 김현수 (Department of Pathology and Translational Genomics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea) Wen-Fang Cheng (National Taiwan University Hospital, Taipei, Taiwan) Yu-Li Chen (Department of Obstetrics and Gynecology, College of Medicine, National Taiwan University)
저널정보
대한부인종양학회 Journal of Gynecologic Oncology Journal of Gynecologic Oncology Vol.35 No.3
발행연도
2024.5
수록면
1 - 13 (13page)
DOI
https://doi.org/10.3802/jgo.2024.35.e33

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objective: In early-stage endometrial cancer, aggressive histologic types (grade 3endometrioid, serous, clear cell, carcinosarcomas, undifferentiated, mixed, and otherunusual types) are associated with an increased risk of distant metastases and worse sur vival. However, the optimal adjuvant treatment for these patients remains controversial. Thepresent study investigated the outcomes of different adjuvant treatments in patients with2023 FIGO stage IIC endometrial cancer. Methods: We retrospectively identified patients with 2023 FIGO stage IIC endometrial cancerwho under went surger y followed by either adjuvant treatment or obser vation from 2000 to2020 at two tertiar y centers in Korea and Taiwan. Recurrence-free sur vival (RFS) and overallsur vival (OS) were evaluated using Kaplan-Meier estimates and Cox proportional-hazardsmodels. We also analyzed recurrence patterns after different adjuvant treatments. Results: A total of 272 patients were identified; 204 received adjuvant treatment postoperatively,whereas 68 only under went obser vation. Adjuvant treatment was not associated with improvedRFS or OS. Non-endometrioid histologic types (p=0.003) and presence of lymphovascular spaceinvasion (LVSI, p=0.002) were associated with worse RFS, whereas only non-endometrioidhistologic types impacted OS (p=0.004). In subgroup analyses, adjuvant treatment improvedOS in patients with LVSI (p=0.020) and in patients with both LVSI and grade 3 endometrioidhistologic type (p=0.007). We found no difference in locoregional and distant recurrencebetween patients undergoing adjuvant treatment or obser vation. Conclusion: In this study, the addition of adjuvant treatment was associated with an OSbenefit for patients with LVSI, especially those with grade 3 endometrioid tumors.

목차

등록된 정보가 없습니다.

참고문헌 (0)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

최근 본 자료

전체보기

댓글(0)

0